UK
UK launches drug testing service for illicit drugs
February 25, 2019Sales and Marketing Home office, UK, cocaine, drugs, fentanyl, illicit substances, recreational drugs
The UK Home Office have licensed a drug-checking service for users of illicit substances. The yearlong pilot project, run by …
Avara Avlon falls into administration putting 270 Bristol jobs at risk
February 21, 2019Manufacturing and Production AstraZeneca, Avara Avlon, Bristol, CDMO, Jobs, UK, manufacturing
Bristol-based pharma firm Avara Avlon Pharmaceuticals has fallen into administration putting the jobs of all 270 of its staff at …
Australian firm Althea enters UK medicinal cannabis market
February 13, 2019Research and Development Epidiolex, GW Pharma, Medical marijuana, NHS, UK, cannabis
Melbourne-based medicinal cannabis company Althea has become one of the first companies to enter the UK market after the British …
Clinigen shares soar after $210m Novartis cancer drug deal
February 13, 2019Research and Development Cancer, Clinigen, Novartis, Proleukin, UK, US, oncology
British company Clinigen has bought the rights to sell Novartis’ cancer drug Proleukin in the United States in a deal …
33% of antibiotics prescribed by NHS are given without associated diagnosis, England’s Chief Medical Officer warns
February 11, 2019Sales and Marketing AMR, Antibiotics, Dame Sally Davies, England, UK, pharma
A third of the antibiotics prescribed by the NHS are given out despite there being no medical evidence that they …
FMD would not apply in case of no-deal Brexit
February 8, 2019Medical Communications EU, FMD, UK, brexit, falsified medicines
The Falsified Medicines Directive would be scrapped in the event of a no deal Brexit, the Association of the British …
NICE joins forces with Canadian peer to offer scientific advice to the pharma industry
February 6, 2019Research and Development, Sales and Marketing CADTH, Canada, NICE, UK, pharma
NICE has announced a collaboration with its Canadian counterpart, the Canadian Agency for Drugs and Technology in Health (CADTH), with …
More than 200 Xanax-related deaths in UK since 2015
February 5, 2019Manufacturing and Production Pfizer, UK, benzodiazepines, health, public health, xanax
There have been more than 200 deaths linked to misuse of the anti-anxiety drug Xanax in the UK since 2015. …
100,000 extra GP appointments to be made available in Gloucestershire as part of NHS Long Term Plan
February 4, 2019Sales and Marketing GP, Gloucestershire, NHS, UK, britain, primare care
GP practices in Gloucestershire are set to offer 100,000 more appointments for patients in the coming year. The initiative comes …
Cambridgeshire and Peterborough NHS Foundation Trust launches mental health clinical trials
February 4, 2019Sales and Marketing UK, clinical trials, clozapine, mental health, schizophrenia
The Cambridgeshire and Peterborough NHS Foundation Trust’s Windsor Research Unit is offering patients the chance to participate in clinical trials …
ABPI warns of skills shortage in UK caused by lack of STEM grads and Brexit
January 30, 2019Research and Development ABPI, UK, eomployment, skills, stem, work
The UK is falling behind Europe and the rest of the world in regards to the number of students studying …
Philip Hampton to step down from chairman role at GSK
January 28, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, UK, appointment, pharma
Sir Philip Hampton is stepping down from his role as non-executive chairman of British multinational GlaxoSmithKline. The resignation comes just …
Novartis warns of huge impact of no-deal Brexit
January 28, 2019Sales and Marketing EU, Novartis, UK, brexit, no-deal, pharma
Swiss pharmaceutical company Novartis has called on the British government to ‘ensure continuity of supply’ in the case of a …
NHS App begins public rollout across England following successful testing
January 24, 2019Medical Communications England, NHS, NHS App, UK, health, pharma
NHS England has announced that the NHS app, which will allow patients to book and manage their GP appointments alongside …
UK government launches plan to control AMR by 2040
January 24, 2019Medical Communications, Research and Development AMR, Antibiotics, Davos, Matt Hancock, UK
The British government has announced a plan through which it will incentivise pharmaceutical companies to develop drugs aimed at tackling …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
